| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |